Physician profile
Stephen Beecroft
NPI 1801039367
$560.61
in general payments reported to CMS, 2019-2025
8 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.70 · 2022: $29.87 · 2023: $248 · 2024: $127 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $136.76 | 2025 | 3m, Clarity Aligners, Apc Flash-Free Victory Series Low Profile |
| Align Technology, INC. | $136.34 | 2020-2024 | Invisalign, Itero Element 5d Plus Lite |
| Envista Holdings Corporation | $75.43 | 2024 | Spark |
| American Orthodontics Corporation | $61.46 | 2022-2023 | Master Series, Empower-Metal, Lp and Ifit Tubes |
| Ortho Organizers, INC. | $51.25 | 2023 | Carriere |
| Ormco Corporation | $39.98 | 2023 | Spark |
| Nobel Biocare USA | $39.97 | 2023 | Nobelactive |
| 3m Company | $19.42 | 2023 | Clarity Aligners |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Beecroft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.